ReP USP - Resultado da busca

Filtros : "NEFROPATIAS" "IB" Limpar

Filtros

USP affiliated authors
- carramaschi, lygia da veiga pereira (~1)
- ferrari, merari de fatima ramires (~1)
- giudicelli, giovanna câmara (~1)
- hünemeier, tábita (~1)
Date published
- 2022 (~1)
- 2019 (~1)
Subjects
- nefropatias (2)
- genealogia (1)
- genética (1)
- genética médica (1)
- miscigenação (1)

Artigo de periodico
Precision medicine implementation challenges for APOL1 testing in chronic kidney disease in admixed populations (2022)
Giudicelli, Giovanna Câmara; Souza, Celia Mariana Barbosa De; Veronese, Francisco Veríssi; Pereira, Lygia da Veiga ; Hünemeier, Tábita ; Vianna, Fernanda Sales
Source: Frontiers in Genetics. Unidade: IB
Subjects: GENÉTICA, NEFROPATIAS, MISCIGENAÇÃO, GENEALOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GIUDICELLI, Giovanna Câmara et al. Precision medicine implementation challenges for APOL1 testing in chronic kidney disease in admixed populations. Frontiers in Genetics, v. 13, 2022Tradução . . Disponível em: https://doi.org/10.3389/fgene.2022.1016341. Acesso em: 01 nov. 2024.
APA
Giudicelli, G. C., Souza, C. M. B. D., Veronese, F. V., Pereira, L. da V., Hünemeier, T., & Vianna, F. S. (2022). Precision medicine implementation challenges for APOL1 testing in chronic kidney disease in admixed populations. Frontiers in Genetics, 13. doi:10.3389/fgene.2022.1016341
NLM
Giudicelli GC, Souza CMBD, Veronese FV, Pereira L da V, Hünemeier T, Vianna FS. Precision medicine implementation challenges for APOL1 testing in chronic kidney disease in admixed populations [Internet]. Frontiers in Genetics. 2022 ; 13[citado 2024 nov. 01 ] Available from: https://doi.org/10.3389/fgene.2022.1016341
Vancouver
Giudicelli GC, Souza CMBD, Veronese FV, Pereira L da V, Hünemeier T, Vianna FS. Precision medicine implementation challenges for APOL1 testing in chronic kidney disease in admixed populations [Internet]. Frontiers in Genetics. 2022 ; 13[citado 2024 nov. 01 ] Available from: https://doi.org/10.3389/fgene.2022.1016341
Artigo de periodico
Vitamin D3 increases the Caspase-3 p12, MTHFR, and P-glycoprotein reducing amyloid-β42 in the kidney of a mouse model for Down syndrome (2019)
Gomes, Fabiana de Campos ; Melo-Neto, João Simão de ; Ferrari, Merari de Fátima Ramires ; Carlos, Carla Patricia ; Goloni-Bertollo, Eny Maria ; Pavarino, Érika Cristina
Source: Life Sciences. Unidade: IB
Subjects: GENÉTICA MÉDICA, SÍNDROME DE DOWN, VITAMINA D, NEFROPATIAS, MODELOS ANIMAIS DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMES, Fabiana de Campos et al. Vitamin D3 increases the Caspase-3 p12, MTHFR, and P-glycoprotein reducing amyloid-β42 in the kidney of a mouse model for Down syndrome. Life Sciences, v. 231, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.lfs.2019.06.012. Acesso em: 01 nov. 2024.
APA
Gomes, F. de C., Melo-Neto, J. S. de, Ferrari, M. de F. R., Carlos, C. P., Goloni-Bertollo, E. M., & Pavarino, É. C. (2019). Vitamin D3 increases the Caspase-3 p12, MTHFR, and P-glycoprotein reducing amyloid-β42 in the kidney of a mouse model for Down syndrome. Life Sciences, 231. doi:10.1016/j.lfs.2019.06.012
NLM
Gomes F de C, Melo-Neto JS de, Ferrari M de FR, Carlos CP, Goloni-Bertollo EM, Pavarino ÉC. Vitamin D3 increases the Caspase-3 p12, MTHFR, and P-glycoprotein reducing amyloid-β42 in the kidney of a mouse model for Down syndrome [Internet]. Life Sciences. 2019 ; 231[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.lfs.2019.06.012
Vancouver
Gomes F de C, Melo-Neto JS de, Ferrari M de FR, Carlos CP, Goloni-Bertollo EM, Pavarino ÉC. Vitamin D3 increases the Caspase-3 p12, MTHFR, and P-glycoprotein reducing amyloid-β42 in the kidney of a mouse model for Down syndrome [Internet]. Life Sciences. 2019 ; 231[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.lfs.2019.06.012

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024